Functional gastrointestinal disorders in eating disorder patients: Altered distribution and predictors using ROME III compared to ROME II criteria

Table 3 Prevalence of individual functional gastrointestinal disorders present in ROME III with and without 6-mo presence requirement and the prevalence of these in ROME II

	ROME III (n = 100)		ROME II (n = 160)
	With 6-mo requirement	With 3-mo requirement	Present 3 mo or more
A1: Functional Heartburn1	22%	26%	24%
A2: Functional Chest Pain of Presumed Esophageal Origin1	8%	17%	4%
A3: Functional Dysphagia1	6%	16%	9%
A4: Globus1	1%	2%	5%
B1: Functional Dyspepsia1	0%	57%	7%
B1a: Postprandial Distress Syndrome1	45%	72%	-
B2a: Aerophagia1	14% (a,b combined)	18% (a,b combined)	11%
B2b: Unspecified Excessive Belching1			-
B3a: Chronic idiopathic nausea1	10%	14%	-
B3c: Cyclic vomiting syndrome	17%	19%	-
B4: Rumination Syndrome in Adults1	7%	7%	2%
C1: Irritable Bowel Syndrome1	41%	57%	45%
C2: Functional Bloating1	1%	3%	30%
C3: Functional Constipation1	11%	27%	26%
C5: Unspecified Functional Bowel Disorder1	24%	18%	-
F1: Functional Fecal Incontinence (3 mo)	15%	15%	11%
F2a: Chronic Proctalgia1	5%	5%	-
F2b: Proctalgia Fugax (3 mo)	11%	11%	21%

¹FGID in ROME III and ROME II; B3b. Functional vomiting¹ is excluded for ED patients. Prevalences of individual FGID < 5 excluded from table, B1b: Epigastric pain syndrome¹; C4: Functional diarrhea¹; D: Functional abdominal pain syndrome; E: Functional gallbladder and sphincter of oddi disorders; E1: Functional gallbladder disorder; E2: Functional biliary sphincter of oddi disorder; E3: Functional pancreatic sphincter of oddi disorder; F3: Functional defecation disorders.